| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3385586 | Revista Colombiana de Reumatología | 2010 | 7 Pages |
Abstract
The use of anti-TNF in patients that disease previously resistant to conventional DMAR achieved a 45% EULAR remission. The age in which the therapy starts; long-standing disease and the higher DAS 28, are negative predictors of treatment response to anti-TNF therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
José Francisco DÃaz-Coto, Francisco Brenes Silesky,